1995
DOI: 10.1111/j.1442-200x.1995.tb03681.x
|View full text |Cite
|
Sign up to set email alerts
|

Standard and intermediate risk acute lymphoblastic leukemia in Poland: A report of the Polish Children's Leukemia/Lymphoma Study Group

Abstract: A total of 527 children with acute lymphoblastic leukaemia (ALL) from the most frequent risk groups: standard risk group (SRG) and intermediate risk group (IRG) were treated between 1987 and 1991 according to an intensified treatment program (based on the BFM protocol) including the use of an intermediate dose of methotrexate in the IRG. A comparison of the treatment results in this group from 513 children treated between 1981 and 1987 indicates that the chance for a 6 year event‐free survival has increased to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

1998
1998
2019
2019

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 14 publications
0
4
0
Order By: Relevance
“…ALL therapy was conducted according to modified BFM regimen with subsequent revisions (147 patients) or New York regimen (44 patients); details concerning treatment regimens have been published elsewhere (Radwanska et al 1989(Radwanska et al , 1995Balwierz et al 2003). The children were treated from 11 June 1979 through 24 August 2005.…”
Section: Methodsmentioning
confidence: 99%
“…ALL therapy was conducted according to modified BFM regimen with subsequent revisions (147 patients) or New York regimen (44 patients); details concerning treatment regimens have been published elsewhere (Radwanska et al 1989(Radwanska et al , 1995Balwierz et al 2003). The children were treated from 11 June 1979 through 24 August 2005.…”
Section: Methodsmentioning
confidence: 99%
“…Second CRT (18 Gy) was applied in 1 patient. Details concerning ALL treatment protocols were published elsewhere [ 14 - 16 ]. Demographic and clinical data of the patients are provided in table 1 .…”
Section: Methodsmentioning
confidence: 99%
“…1). CLS were treated, from 1990 to 2005, according to the protocols of the Polish Paediatric Leukaemia/Lymphoma Study Group based on the Berlin-Frankfurt-Munster group protocols, the French Society for Paediatric Oncology Group regimen LMB (lymphoma malignum type B), modified protocols for high-risk acute leukaemia New York II, and REZBFM 96 for five patients with a relapse [2124]. All patients were Caucasian, and their characteristics are shown in Table 1.
Fig.
…”
Section: Resultsmentioning
confidence: 99%